The European Union's CHMP has recommended the approval of AstraZeneca and Ionis Pharmaceuticals’ Wainzua to treat ATTRv-PN.

Hindustan Unilever’s Q2 net profit is expected to remain flat at ₹2,670 crore as against ₹2,668 crore, year-on-year (YoY).

GSK plc (LSE/NYSE: GSK) announced it is investing £50 million into a major new five-year collaboration with the University of ...

Earnings before interest, tax, depreciation, and amortisation (Ebitda) is likely to remain flat at Rs 3,698.7 crore on an ...

The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

A city off-licence has had its licence suspended for six weeks after the owner was caught twice selling illegal goods.

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Sanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for ...

According to a Moneycontrol poll of seven brokerages, Hindustan Unilever is likely to report a revenue growth higher by 4.4 percent on-year, at Rs 15,694 crore.